132 related articles for article (PubMed ID: 3246686)
1. Natural, lectin- and phorbol ester-induced cellular cytotoxicity in Crohn's disease and ulcerative colitis.
Aparicio-Pagés MN; Verspaget HW; Peña AS; Weterman IT; Mieremet-Ooms MA; van der Zon JM; de Bruin PA; Lamers CB
J Clin Lab Immunol; 1988 Nov; 27(3):109-13. PubMed ID: 3246686
[TBL] [Abstract][Full Text] [Related]
2. In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.
Aparició-Pagés MN; Verspaget HW; Peña AS; Weterman IT; de Bruin PA; Mieremet-Ooms MA; van der Zon JM; van Tol EA; Lamers CB
J Clin Lab Immunol; 1989 Jul; 29(3):119-24. PubMed ID: 2517428
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
MacDermott RP; Bragdon MJ; Thurmond RD
Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
[TBL] [Abstract][Full Text] [Related]
4. Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.
Auer IO; Ziemer E; Sommer H
Clin Exp Immunol; 1980 Oct; 42(1):41-9. PubMed ID: 7460390
[TBL] [Abstract][Full Text] [Related]
5. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect.
Ginsburg CH; Dambrauskas JT; Ault KA; Falchuk ZM
Gastroenterology; 1983 Oct; 85(4):846-51. PubMed ID: 6884709
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell function and lymphocyte subpopulation profiles in inflammatory bowel disease.
Brown TE; Bankhurst AD; Strickland RG
J Clin Lab Immunol; 1983 Jul; 11(3):113-7. PubMed ID: 6224936
[TBL] [Abstract][Full Text] [Related]
7. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
Melgar S; Hammarström S; Oberg A; Danielsson A; Hammarström ML
Scand J Immunol; 2004; 60(1-2):167-77. PubMed ID: 15238086
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell activity in patients with inflammatory bowel disease.
Egawa S; Hiwatashi N
J Clin Lab Immunol; 1986 Aug; 20(4):187-92. PubMed ID: 3093683
[TBL] [Abstract][Full Text] [Related]
9. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
10. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
[TBL] [Abstract][Full Text] [Related]
13. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
[TBL] [Abstract][Full Text] [Related]
14. T cell subpopulations in inflammatory bowel disease: evidence for a defective induction of T8+ suppressor/cytotoxic T lymphocytes.
Goronzy J; Weyand CM; Waase I
Clin Exp Immunol; 1985 Sep; 61(3):593-600. PubMed ID: 2934188
[TBL] [Abstract][Full Text] [Related]
15. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
16. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
Lyanga J; Davis P; Thomson AB
West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
[TBL] [Abstract][Full Text] [Related]
17. Immunological studies on Crohn's disease. III. Defective natural killer activity.
Okabe N; Fujita K; Yao T
J Clin Lab Immunol; 1985 Jul; 17(3):143-6. PubMed ID: 4046002
[TBL] [Abstract][Full Text] [Related]
18. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
[TBL] [Abstract][Full Text] [Related]
19. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
20. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
